Twist Bioscience Statistics
Share Statistics
Twist Bioscience has 59.92M
shares outstanding. The number of shares has increased by 2.45%
in one year.
| Shares Outstanding | 59.92M |
| Shares Change (YoY) | 2.45% |
| Shares Change (QoQ) | 0.5% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 579 |
| FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 10.62M, so 17.72% of the outstanding
shares have been sold short.
| Short Interest | 10.62M |
| Short % of Shares Out | 17.72% |
| Short % of Float | 20.01% |
| Short Ratio (days to cover) | 7.88 |
Valuation Ratios
The PE ratio is -12.56 and the forward
PE ratio is -21.26.
Twist Bioscience's PEG ratio is
0.
| PE Ratio | -12.56 |
| Forward PE | -21.26 |
| PS Ratio | 8.38 |
| Forward PS | 2.4 |
| PB Ratio | 5.55 |
| P/FCF Ratio | -37.89 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Twist Bioscience.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.88,
with a Debt / Equity ratio of 0.18.
| Current Ratio | 4.88 |
| Quick Ratio | 4.54 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | -0.48 |
| Debt / FCF | -1.23 |
| Interest Coverage | -7614.86 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $339,083.42 |
| Profits Per Employee | $-226,138.68 |
| Employee Count | 923 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 7.46 |
Taxes
| Income Tax | 560K |
| Effective Tax Rate | -0.27% |
Stock Price Statistics
The stock price has increased by -30.07% in the
last 52 weeks. The beta is 2.54, so Twist Bioscience's
price volatility has been higher than the market average.
| Beta | 2.54 |
| 52-Week Price Change | -30.07% |
| 50-Day Moving Average | 35.95 |
| 200-Day Moving Average | 42.76 |
| Relative Strength Index (RSI) | 39.6 |
| Average Volume (20 Days) | 1,243,317 |
Income Statement
In the last 12 months, Twist Bioscience had revenue of 312.97M
and earned -208.73M
in profits. Earnings per share was -3.6.
| Revenue | 312.97M |
| Gross Profit | 133.35M |
| Operating Income | -220.83M |
| Net Income | -208.73M |
| EBITDA | -176.71M |
| EBIT | -208.14M |
| Earnings Per Share (EPS) | -3.6 |
Full Income StatementBalance Sheet
The company has 226.32M in cash and 85.03M in
debt, giving a net cash position of 141.29M.
| Cash & Cash Equivalents | 226.32M |
| Total Debt | 85.03M |
| Net Cash | 141.29M |
| Retained Earnings | -1.24B |
| Total Assets | 595.62M |
| Working Capital | 263.47M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -64.09M
and capital expenditures -5.08M, giving a free cash flow of -69.17M.
| Operating Cash Flow | -64.09M |
| Capital Expenditures | -5.08M |
| Free Cash Flow | -69.17M |
| FCF Per Share | -1.19 |
Full Cash Flow StatementMargins
Gross margin is 42.61%, with operating and profit margins of -70.56% and -66.69%.
| Gross Margin | 42.61% |
| Operating Margin | -70.56% |
| Pretax Margin | -66.51% |
| Profit Margin | -66.69% |
| EBITDA Margin | -56.46% |
| EBIT Margin | -70.56% |
| FCF Margin | -22.1% |
